Cobimetinib Plus Vemurafenib: A Review in BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma
Crossref DOI link: https://doi.org/10.1007/s40265-016-0562-7
Published Online: 2016-03-16
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Keating, Gillian M.
Text and Data Mining valid from 2016-03-16